Jing Jin's Insider Trades & SAST Disclosures
Jing Jin's most recent trade in SES AI Corporation - Ordinary Shares - Class A was a trade of 11,056 Class A Common Stock done at an average price of $0.4 . Disclosure was reported to the exchange on March 17, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jing Jin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.44 per share. | 17 Mar 2025 | 11,056 | 1,817,977 | - | 0.4 | 4,862 | Class A Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 45,715 | 45,715 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 34,285 | 101,485 (0%) | 0% | 0 | Common Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 17 Feb 2025 | 12,604 | 1,829,033 | - | 1.0 | 12,856 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.17 per share. | 10 Feb 2025 | 80,992 | 1,841,637 | - | 1.2 | 94,866 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 16 Jan 2025 | 50,000 | 1,985,322 | - | 0.2 | 8,000 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 16 Jan 2025 | 50,000 | 1,935,322 | - | 1.0 | 51,000 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 50,000 | 886,555 | - | - | Stock Option (Right to Buy) | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.04 per share. | 16 Jan 2025 | 12,693 | 1,922,629 | - | 1.0 | 13,201 | Class A Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 44.20 per share. | 16 Jan 2025 | 5,655 | 67,200 (0%) | 0% | 44.2 | 249,935 | Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Dec 2024 | 150,000 | 936,555 | - | - | Stock Option (Right to Buy) | |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 26 Dec 2024 | 150,000 | 2,085,322 | - | 0.2 | 24,000 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 26 Dec 2024 | 150,000 | 1,935,322 | - | 1.0 | 153,000 | Class A Common Stock |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. | 16 Dec 2024 | 11,025 | 1,935,322 | - | 0.4 | 4,540 | Class A Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 6,375 | 130,000 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 22 Nov 2024 | 6,375 | 79,230 (0%) | 0% | 8.6 | 54,761 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.93 per share. | 22 Nov 2024 | 3,075 | 73,055 (0%) | 0% | 39.9 | 122,780 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 22 Nov 2024 | 2,145 | 75,000 (0%) | 0% | 8.6 | 18,426 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Nov 2024 | 2,145 | 136,375 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.01 per share. | 22 Nov 2024 | 2,145 | 72,855 (0%) | 0% | 30.0 | 64,372 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 39.25 per share. | 22 Nov 2024 | 2,100 | 76,130 (0%) | 0% | 39.3 | 82,434 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 38.04 per share. | 22 Nov 2024 | 1,000 | 78,230 (0%) | 0% | 38.0 | 38,041 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 40.72 per share. | 22 Nov 2024 | 200 | 72,855 (0%) | 0% | 40.7 | 8,144 | Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 18 Nov 2024 | 11,025 | 1,946,347 | - | 0.3 | 2,975 | Class A Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 11 Nov 2024 | 2,105 | 74,960 (0%) | 0% | 8.6 | 18,082 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Nov 2024 | 2,105 | 138,520 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 11 Nov 2024 | 2,105 | 72,855 (0%) | 0% | 30.0 | 63,158 | Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.61 per share. | 16 Oct 2024 | 11,025 | 1,957,372 | - | 0.6 | 6,748 | Class A Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.59 per share. | 07 Oct 2024 | 109,375 | 182,230 (0%) | 0% | 8.6 | 939,531 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Oct 2024 | 109,375 | 140,625 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.59 per share. | 07 Oct 2024 | 67,448 | 114,782 (0%) | 0% | 25.6 | 1,725,893 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 30.06 per share. | 07 Oct 2024 | 39,375 | 72,855 (0%) | 0% | 30.1 | 1,183,652 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.22 per share. | 07 Oct 2024 | 2,552 | 112,230 (0%) | 0% | 26.2 | 66,923 | Common Stock |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 111,024 | 111,024 | - | - | Stock Option (right to buy) | |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2024 | 71,274 | 193,145 | - | 0 | Common Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 16 Sep 2024 | 32,487 | 2,011,909 | - | 0.2 | 5,198 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 32,487 | 1,104,068 | - | - | Stock Option (Right to Buy) | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.02 per share. | 16 Sep 2024 | 32,487 | 1,979,422 | - | 1.0 | 33,237 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2024 | 17,513 | 1,086,555 | - | - | Stock Option (Right to Buy) | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.30 per share. | 16 Sep 2024 | 17,513 | 1,979,422 | - | 1.3 | 22,767 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 16 Sep 2024 | 17,513 | 1,996,935 | - | 0.2 | 2,802 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 16 Sep 2024 | 11,025 | 1,968,397 | - | 1.0 | 11,246 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2024 | 50,000 | 1,136,555 | - | - | Stock Option (Right to Buy) | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 29 Aug 2024 | 50,000 | 1,979,422 | - | 1.1 | 52,510 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.16 per share. | 29 Aug 2024 | 50,000 | 2,029,422 | - | 0.2 | 8,000 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 19 Aug 2024 | 11,025 | 1,979,422 | - | 1.0 | 11,246 | Class A Common Stock |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 11 Aug 2024 | 6,715 | 121,871 | - | 1.3 | 8,461 | Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.35 per share. | 16 Jul 2024 | 11,025 | 1,990,447 | - | 1.4 | 14,884 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.20 per share. | 16 Jun 2024 | 11,024 | 2,001,472 | - | 1.2 | 13,229 | Class A Common Stock |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 15,000 | 15,000 | - | - | Stock option (right to buy) | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 3,131 (0%) | 0% | 0 | Common Stock | |
| Arcturus Therapeutics Hold... | Jing L. Marantz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 3,131 | 0 | - | - | Deferred Stock Units | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.27 per share. | 16 May 2024 | 11,025 | 2,012,496 | - | 1.3 | 14,002 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.34 per share. | 18 Apr 2024 | 26,576 | 2,023,521 | - | 1.3 | 35,612 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 15 Apr 2024 | 24,881 | 2,061,122 | - | 1.5 | 37,073 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.49 per share. | 15 Apr 2024 | 11,025 | 2,050,097 | - | 1.5 | 16,427 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 34 | 13,795 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.52 per share. | 15 Mar 2024 | 11,025 | 2,084,366 | - | 1.5 | 16,758 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 114.75 per share. | 15 Mar 2024 | 581 | 22,684 (0%) | 0% | 114.8 | 66,670 | Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 35 | 13,760 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 2,279 | 13,725 | - | - | Phantom Stock | |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 1.23 per share. | 07 Mar 2024 | 6,235 | 128,586 | - | 1.2 | 7,690 | Common Stock |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 1.26 per share. | 07 Mar 2024 | 4,642 | 134,821 | - | 1.3 | 5,854 | Common Stock |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 07 Mar 2024 | 4,048 | 139,463 | - | 1.3 | 5,383 | Common Stock |
| Tigo Energy Inc. | Jing Tian | Chief Growth Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 30,021 | 143,511 | - | 0 | Common Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 22 | 11,445 | - | - | Phantom Stock | |
| Allied Gaming & Entertainm... | Lu Jingsheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 40,000 | 40,000 | - | - | Stock Options (right to buy) | |
| Allied Gaming & Entertainm... | Lu Jingsheng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share | |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. | 16 Feb 2024 | 12,662 | 2,095,391 | - | 1.4 | 18,233 | Class A Common Stock |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.44 per share. | 16 Feb 2024 | 11,025 | 2,097,028 | - | 1.4 | 15,876 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 23 | 11,423 | - | - | Phantom Stock | |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 8,071 | 8,071 | - | - | Employee Stock Options (Right to Buy) | |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 108.38 per share. | 13 Feb 2024 | 1,943 | 23,265 (0%) | 0% | 108.4 | 210,582 | Common Stock |
| Scholar Rock Holding Corp | Jing L. Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 97,145 | 97,145 | - | - | Stock Option (Right to Buy) | |
| Scholar Rock Holding Corp | L. Jing Marantz | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 72,855 | 72,855 (0%) | 0% | 0 | Common Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 6,948 | 23,228 (0%) | 0% | 0 | Common Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 109.07 per share. | 12 Feb 2024 | 1,906 | 21,322 (0%) | 0% | 109.1 | 207,887 | Common Stock |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 610,593 | 2,108,053 | - | 0 | Class A Common Stock | |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2024 | 610,593 | 610,593 | - | - | Performance Vesting Restricted Share Units | |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 108.16 per share. | 09 Feb 2024 | 520 | 16,281 (0%) | 0% | 108.2 | 56,243 | Common Stock |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 24 | 11,399 | - | - | Phantom Stock | |
| Tigo Energy Inc. | Tian Jing | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2024 | 70,012 | 23,332 | - | - | Stock Option (right to buy) | |
| Tigo Energy Inc. | Tian Jing | Chief Growth Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.69 per share. | 19 Jan 2024 | 70,012 | 113,490 | - | 0.7 | 48,308 | Common Stock |
| SES AI Corporation - Ordin... | Nealis Jing | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.38 per share. | 16 Jan 2024 | 12,662 | 1,497,460 | - | 1.4 | 17,474 | Class A Common Stock |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2024 | 24 | 11,294 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 55 | 11,270 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.09 per share. | 18 Dec 2023 | 11,242 | 1,510,122 | - | 2.1 | 23,538 | Class A Common Stock |
| Ingredion Inc | Xu Jinghuai | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2023 | 56 | 11,214 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 59 | 11,157 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.37 per share. | 17 Nov 2023 | 10,802 | 1,521,364 | - | 2.4 | 25,649 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 58 | 11,098 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2023 | 64 | 11,040 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.51 per share. | 17 Oct 2023 | 10,910 | 1,532,166 | - | 2.5 | 27,366 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Oct 2023 | 66 | 10,884 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.40 per share. | 29 Sep 2023 | 1,035 | 16,675 (0%) | 0% | 98.4 | 101,844 | Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 61 | 10,818 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.13 per share. | 18 Sep 2023 | 11,280 | 1,543,076 | - | 2.1 | 24,072 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2023 | 61 | 10,757 | - | - | Phantom Stock | |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Aug 2023 | 58 | 10,695 | - | - | Phantom Stock | |
| SES AI Corporation - Ordin... | Jing Nealis | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 2.12 per share. | 18 Aug 2023 | 10,895 | 1,554,356 | - | 2.1 | 23,129 | Class A Common Stock |
| Ingredion Inc | Jinghuai Xu | SVP, Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 62 | 10,637 | - | - | Phantom Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges